{"id":4736,"date":"2023-10-05T14:53:53","date_gmt":"2023-10-05T12:53:53","guid":{"rendered":"https:\/\/uuinvest.se\/?post_type=dt_portfolio&p=4736"},"modified":"2023-10-05T14:53:53","modified_gmt":"2023-10-05T12:53:53","slug":"mycural-therapeutics","status":"publish","type":"dt_portfolio","link":"https:\/\/uuinvest.se\/en\/project\/mycural-therapeutics\/","title":{"rendered":"MyCural Therapeutics"},"content":{"rendered":"

[vc_row full_width=”stretch_row” css=”.vc_custom_1613137276426{background-color: #021626 !important;}” el_class=”project-row”][vc_column][vc_empty_space height=”200px” el_class=”page-intro-space”][vc_btn title=”Tillbaka” style=”custom” custom_background=”rgba(255,255,255,0.01)” custom_text=”#f87052″ shape=”square” align=”left” src=”“https:\/\/uuinvest.se\/wp-content\/uploads\/2021\/02\/left-arrow.png“” el_class=”back-btn” link=”url:https%3A%2F%2Fuuinvest.se%2Fen%2Fportfolj%2F|title:Tillbaka|”][vc_custom_heading text=”MyCural Therapeutics” font_container=”tag:h1|text_align:left|color:%23ffffff” use_theme_fonts=”yes” el_class=”page-title” css=”.vc_custom_1696509972347{padding-top: 0px !important;}”][\/vc_column][vc_column width=”7\/12″][vc_column_text el_class=”portfolio-single-intro”]MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. The company is built on world-leading research and knowledge of the dysregulated oncoprotein MYC and methods to study its interaction with other proteins. The company has developed small molecules and is focused on developing cancer drugs for the treatment of so-called high-risk tumors.[\/vc_column_text][vc_column_text el_class=”portfolio-single-intro”][\/vc_column_text][vc_column_text el_class=”portfolio-single-contet”][\/vc_column_text][\/vc_column][vc_column width=”1\/3″ offset=”vc_col-lg-offset-1 vc_col-md-offset-1 vc_col-sm-offset-1″][vc_column_text el_class=”project-data”]<\/p>\n

START YEAR<\/h5>\n

2022<\/p>\n

INVESTMENT<\/h5>\n

2022<\/p>\n

CEO<\/h5>\n

Alina Castell<\/p>\n

CONTACT<\/h5>\n

alina.castell@mycural.com<\/p>\n

WEBSITE<\/h5>\n

mycural.com<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1613604924552{background-color: #021626 !important;}” el_class=”next-prev-row-dr”][vc_column]

<\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch_row” css=”.vc_custom_1613137276426{background-color: #021626 !important;}” el_class=”project-row”][vc_column][vc_empty_space height=”200px” el_class=”page-intro-space”][vc_btn title=”Tillbaka” style=”custom” custom_background=”rgba(255,255,255,0.01)” custom_text=”#f87052″ shape=”square”…<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","dt_portfolio_category":[],"dt_portfolio_tags":[],"class_list":["post-4736","dt_portfolio","type-dt_portfolio","status-publish","hentry","description-off"],"acf":[],"yoast_head":"\nMyCural Therapeutics - Uppsala University Invest<\/title>\n<meta name=\"description\" content=\"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MyCural Therapeutics - Uppsala University Invest\" \/>\n<meta property=\"og:description\" content=\"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Uppsala University Invest\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/project\\\/mycural-therapeutics\\\/\",\"url\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/project\\\/disruptive-pharma\\\/\",\"name\":\"MyCural Therapeutics - Uppsala University Invest\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#website\"},\"datePublished\":\"2023-10-05T12:53:53+00:00\",\"description\":\"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/project\\\/disruptive-pharma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/uuinvest.se\\\/en\\\/project\\\/disruptive-pharma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/project\\\/disruptive-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\",\"item\":\"https:\\\/\\\/uuinvest.se\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MyCural Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#website\",\"url\":\"https:\\\/\\\/uuinvest.se\\\/\",\"name\":\"Uppsala University Invest\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/uuinvest.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MyCural Therapeutics - Uppsala University Invest","description":"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/","og_locale":"en_US","og_type":"article","og_title":"MyCural Therapeutics - Uppsala University Invest","og_description":"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.","og_url":"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/","og_site_name":"Uppsala University Invest","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/uuinvest.se\/en\/project\/mycural-therapeutics\/","url":"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/","name":"MyCural Therapeutics - Uppsala University Invest","isPartOf":{"@id":"https:\/\/uuinvest.se\/#website"},"datePublished":"2023-10-05T12:53:53+00:00","description":"MyCural Therapeutics AB is developing methods and small molecules to treat aggressive cancer. Built on world-leading research and knowledge.","breadcrumb":{"@id":"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/uuinvest.se\/en\/project\/disruptive-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/uuinvest.se\/en\/"},{"@type":"ListItem","position":2,"name":"Portfolio","item":"https:\/\/uuinvest.se\/project\/"},{"@type":"ListItem","position":3,"name":"MyCural Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/uuinvest.se\/#website","url":"https:\/\/uuinvest.se\/","name":"Uppsala University Invest","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/uuinvest.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/4736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio"}],"about":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/types\/dt_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/comments?post=4736"}],"version-history":[{"count":3,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/4736\/revisions"}],"predecessor-version":[{"id":4740,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/4736\/revisions\/4740"}],"wp:attachment":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/media?parent=4736"}],"wp:term":[{"taxonomy":"dt_portfolio_category","embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio_category?post=4736"},{"taxonomy":"dt_portfolio_tags","embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/dt_portfolio_tags?post=4736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}